Related Experiment Video
Updated: May 27, 2026

06:38
Mechanical Vessel Injury in Zebrafish Embryos
Published on: February 17, 2015
Using zebrafish (Danio rerio) to assess gene function in thrombus formation.
Christopher M Williams1, Alastair W Poole
1Department of Physiology & Pharmacology, School of Medical Sciences, University of Bristol, Bristol, UK.
Methods in Molecular Biology (Clifton, N.J.)
|December 2, 2011
Summary
Cardiovascular diseases are a major cause of death. This study explores the zebrafish model for effective screening of novel genes involved in platelet function and thrombosis, aiding vascular disease management.
Area of Science:
- Cardiovascular research
- Thrombosis and hemostasis
- Zebrafish genetics
Background:
- Cardiovascular and cerebrovascular diseases are leading causes of death globally.
- Platelets are key targets for managing vascular diseases, but antithrombotics can cause bleeding side effects.
- Current mouse models for gene function studies are costly and may not guarantee relevant phenotypes.
Purpose of the Study:
- To highlight the zebrafish as a suitable model for studying thrombosis.
- To discuss current techniques for assessing gene function in zebrafish thrombosis models.
- To propose a framework for constructing an effective genetic screen for thrombosis-related genes.
Main Methods:
- Review of existing literature on zebrafish models for thrombosis research.
- Discussion of techniques for gene function assessment in zebrafish.
- Conceptualization of a genetic screening strategy.
Main Results:
- Zebrafish offer a viable alternative model for thrombosis research.
- Established and emerging techniques allow for gene function analysis in zebrafish.
- A genetic screening approach can be developed for novel gene discovery.
Conclusions:
- Zebrafish provide a powerful platform for understanding platelet function and thrombosis.
- This model facilitates the identification of new therapeutic targets for vascular diseases.
- Developing effective genetic screens in zebrafish is crucial for advancing cardiovascular research.

